Her Majesty's Government whether a strategic commercial unit will be established within NHS England, as recommended in the Accelerated Access Review, and if so, when.
11 July 2017
Consistent with recommendations set out in the Accelerated Access Review, NHS England continues to develop its commercial capacity and capability in relation to medicines procurement as well as the negotiation of bespoke commercial access arrangements for high cost drugs. As part of this, the Commercial Medicines Unit transferred across from the Department to NHS England on 1 April 2017. NHS England is currently in the process of recruiting to a number of other key posts to support the commercial function more broadly.